 Tuberculosis, Pulmonary
"Tuberculosis, Pulmonary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
MYCOBACTERIUM infections of the lung.
| Descriptor ID |
D014397
|
| MeSH Number(s) |
C01.252.410.040.552.846.899 C08.381.922 C08.730.939
|
| Concept/Terms |
Tuberculosis, Pulmonary- Tuberculosis, Pulmonary
- Tuberculoses, Pulmonary
- Pulmonary Tuberculoses
- Pulmonary Tuberculosis
- Pulmonary Consumption
- Consumption, Pulmonary
- Consumptions, Pulmonary
- Pulmonary Consumptions
- Pulmonary Phthisis
- Phthises, Pulmonary
- Phthisis, Pulmonary
- Pulmonary Phthises
|
Below are MeSH descriptors whose meaning is more general than "Tuberculosis, Pulmonary".
Below are MeSH descriptors whose meaning is more specific than "Tuberculosis, Pulmonary".
This graph shows the total number of publications written about "Tuberculosis, Pulmonary" by people in UAMS Profiles by year, and whether "Tuberculosis, Pulmonary" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2021 | 2 | 0 | 2 | | 2020 | 1 | 0 | 1 | | 2017 | 3 | 2 | 5 | | 2016 | 0 | 2 | 2 | | 2015 | 5 | 0 | 5 | | 2014 | 7 | 0 | 7 | | 2013 | 3 | 9 | 12 | | 2012 | 2 | 0 | 2 | | 2011 | 3 | 0 | 3 | | 2009 | 3 | 1 | 4 | | 2008 | 3 | 1 | 4 | | 2007 | 2 | 1 | 3 | | 2006 | 2 | 0 | 2 | | 2003 | 2 | 0 | 2 | | 2002 | 1 | 0 | 1 | | 2001 | 2 | 0 | 2 | | 2000 | 3 | 0 | 3 | | 1999 | 4 | 0 | 4 | | 1998 | 2 | 1 | 3 | | 1997 | 1 | 0 | 1 | | 1996 | 2 | 0 | 2 | | 1995 | 1 | 0 | 1 | | 1993 | 0 | 3 | 3 | | 1991 | 3 | 1 | 4 | | 1989 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Tuberculosis, Pulmonary" by people in Profiles over the past ten years.
-
Pisu D, Huang L, Narang V, Theriault M, Lê-Bury G, Lee B, Lakudzala AE, Mzinza DT, Mhango DV, Mitini-Nkhoma SC, Jambo KC, Singhal A, Mwandumba HC, Russell DG. Single cell analysis of M. tuberculosis phenotype and macrophage lineages in the infected lung. J Exp Med. 2021 09 06; 218(9).
-
Giacalone D, Huang L, Tan S. Exploiting Fluorescent Proteins to Understand Mycobacterium tuberculosis Biology. Methods Mol Biol. 2021; 2314:365-383.
-
Huang L, Ye K, McGee MC, Nidetz NF, Elmore JP, Limper CB, Southard TL, Russell DG, August A, Huang W. Interleukin-2-Inducible T-Cell Kinase Deficiency Impairs Early Pulmonary Protection Against Mycobacterium tuberculosis Infection. Front Immunol. 2019; 10:3103.
-
Bouton TC, Phillips PPJ, Mitnick CD, Peloquin CA, Eisenach K, Patientia RF, Lecca L, Gotuzzo E, Gandhi NR, Butler D, Diacon AH, Martel B, Santillan J, Hunt KR, Vargas D, von Groote-Bidlingmaier F, Seas C, Dianis N, Moreno-Martinez A, Horsburgh CR. An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial. Trials. 2017 Nov 25; 18(1):563.
-
Lefkowitz RY, Mitma AA, Altassan K, Redlich CA. The Limits of Pattern Recognition: Nodular Lung Disease in a Syrian Refugee. Ann Am Thorac Soc. 2017 10; 14(10):1591-1594.
-
Ahmed M, Jiao H, Domingo-Gonzalez R, Das S, Griffiths KL, Rangel-Moreno J, Nagarajan UM, Khader SA. Rationalized design of a mucosal vaccine protects against Mycobacterium tuberculosis challenge in mice. J Leukoc Biol. 2017 06; 101(6):1373-1381.
-
Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O'Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clin Infect Dis. 2017 Jan 15; 64(2):111-115.
-
Lin Y, Feng T, Lan J, Chen C, Qin Z, Wu Y, Shi H, Ye J, Wei C, Wang W, Huang L. Expression of Toll-like Receptor 2 and Toll-like Receptor 4 in Tuberculous Pleural Effusion. Med Chem. 2017; 13(6):569-576.
-
Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O'Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clin Infect Dis. 2017 Jan 15; 64(2):e1-e33.
-
Liu Y, Tan S, Huang L, Abramovitch RB, Rohde KH, Zimmerman MD, Chen C, Dartois V, VanderVen BC, Russell DG. Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo. J Exp Med. 2016 05 02; 213(5):809-25.
-
Wampande EM, Mupere E, Jaganath D, Nsereko M, Mayanja HK, Eisenach K, Boom WH, Gagneux S, Joloba ML. Distribution and transmission of Mycobacterium tuberculosis complex lineages among children in peri-urban Kampala, Uganda. BMC Pediatr. 2015 Sep 30; 15:140.
-
Syed M, Irby J. Airway management of ruptured pulmonary artery "Rasmussen" aneurysm and massive hemoptysis. BMC Res Notes. 2015 Aug 12; 8:346.
-
Colman RE, Schupp JM, Hicks ND, Smith DE, Buchhagen JL, Valafar F, Crudu V, Romancenco E, Noroc E, Jackson L, Catanzaro DG, Rodwell TC, Catanzaro A, Keim P, Engelthaler DM. Detection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon Sequencing. PLoS One. 2015; 10(5):e0126626.
-
Avalos E, Catanzaro D, Catanzaro A, Ganiats T, Brodine S, Alcaraz J, Rodwell T. Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review. PLoS One. 2015; 10(3):e0120470.
-
Dawson R, Diacon AH, Everitt D, van Niekerk C, Donald PR, Burger DA, Schall R, Spigelman M, Conradie A, Eisenach K, Venter A, Ive P, Page-Shipp L, Variava E, Reither K, Ntinginya NE, Pym A, von Groote-Bidlingmaier F, Mendel CM. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis. Lancet. 2015 May 02; 385(9979):1738-1747.
-
Hillery N, Groessl EJ, Trollip A, Catanzaro D, Jackson L, Rodwell TC, Garfein RS, Lin SY, Eisenach K, Ganiats TG, Park D, Valafar F, Rodrigues C, Crudu V, Victor TC, Catanzaro A. The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis. Trials. 2014 Nov 06; 15:434.
-
Patil N, Marco A, Saba H, Samant R, Mukasa L. TB or not TB; don't miss the obvious. J Ark Med Soc. 2014 Nov; 111(6):112-4.
-
Wallis RS, Dawson R, Friedrich SO, Venter A, Paige D, Zhu T, Silvia A, Gobey J, Ellery C, Zhang Y, Eisenach K, Miller P, Diacon AH. Mycobactericidal activity of sutezolid (PNU-100480) in sputum (EBA) and blood (WBA) of patients with pulmonary tuberculosis. PLoS One. 2014; 9(4):e94462.
-
Joloba ML, Johnson JL, Feng PJ, Bozeman L, Goldberg SV, Morgan K, Gitta P, Boom HW, Heilig CM, Mayanja-Kizza H, Eisenach KD. What is the most reliable solid culture medium for tuberculosis treatment trials? Tuberculosis (Edinb). 2014 May; 94(3):311-6.
-
Heilig CM, Feng PJ, Joloba ML, Johnson JL, Morgan K, Gitta P, Boom WH, Mayanja-Kizza H, Eisenach KD, Bozeman L, Goldberg SV. How we determined the most reliable solid medium for studying treatment of tuberculosis. Tuberculosis (Edinb). 2014 May; 94(3):317-22.
-
Trollip AP, Moore D, Coronel J, Caviedes L, Klages S, Victor T, Romancenco E, Crudu V, Ajbani K, Vineet VP, Rodrigues C, Jackson RL, Eisenach K, Garfein RS, Rodwell TC, Desmond E, Groessl EJ, Ganiats TG, Catanzaro A. Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay. Int J Tuberc Lung Dis. 2014 Feb; 18(2):227-32.
-
Mahapatra S, Hess AM, Johnson JL, Eisenach KD, DeGroote MA, Gitta P, Joloba ML, Kaplan G, Walzl G, Boom WH, Belisle JT. A metabolic biosignature of early response to anti-tuberculosis treatment. BMC Infect Dis. 2014 Jan 31; 14:53.
-
Bark CM, Gitta P, Ogwang S, Nsereko M, Thiel BA, Boom WH, Eisenach KD, Joloba ML, Johnson JL. Comparison of time to positive and colony counting in an early bactericidal activity study of anti-tuberculosis treatment. Int J Tuberc Lung Dis. 2013 Nov; 17(11):1448-51.
-
Mishra G, Kumar N, Kaur G, Jain S, Tiwari PK, Mehra NK. Distribution of HLA-A, B and DRB1 alleles in Sahariya tribe of North Central India: an association with pulmonary tuberculosis. Infect Genet Evol. 2014 Mar; 22:175-82.
-
Ichiho HM, Tolenoa N, Taulung L, Mongkeya M, Lippwe K, Aitaoto N. An assessment of non-communicable diseases, diabetes, and related risk factors in the Federated States of Micronesia, State of Kosrae: a systems perspective. Hawaii J Med Public Health. 2013 May; 72(5 Suppl 1):39-48.
-
Ichiho HM, Gillan JW, Aitaoto N. An assessment of non-communicable diseases, diabetes, and related risk factors in the Territory of Guam: a systems perspective. Hawaii J Med Public Health. 2013 May; 72(5 Suppl 1):68-76.
-
Ichiho HM, Yurow J, Lippwe K, Aitaoto N. An assessment of non-communicable diseases, diabetes, and related risk factors in the Federated States of Micronesia, State of Yap: a systems perspective. Hawaii J Med Public Health. 2013 May; 72(5 Suppl 1):57-67.
-
Ichiho HM, Robles B, Aitaoto N. An assessment of non-communicable diseases, diabetes, and related risk factors in the commonwealth of the Northern Mariana Islands: a systems perspective. Hawaii J Med Public Health. 2013 May; 72(5 Suppl 1):19-29.
-
Ichiho HM, Anson R, Keller E, Lippwe K, Aitaoto N. An assessment of non-communicable diseases, diabetes, and related risk factors in the Federated States of Micronesia, State of Pohnpei: a systems perspective. Hawaii J Med Public Health. 2013 May; 72(5 Suppl 1):49-56.
-
Ichiho HM, Roby FT, Ponausuia ES, Aitaoto N. An assessment of non-communicable diseases, diabetes, and related risk factors in the territory of American Samoa: a systems perspective. Hawaii J Med Public Health. 2013 May; 72(5 Suppl 1):10-8.
-
Ichiho HM, Shomour M, Marar J, Lippwe K, Aitaoto N. An assessment of non-communicable diseases, diabetes, and related risk factors in the Federated States of Micronesia, State of Chuuk: a systems perspective. Hawaii J Med Public Health. 2013 May; 72(5 Suppl 1):30-8.
-
Ichiho HM, Seremai J, Trinidad R, Paul I, Langidrik J, Aitaoto N. An assessment of non-communicable diseases, diabetes, and related risk factors in the Republic of the Marshall Islands, Kwajelein Atoll, Ebeye Island: a systems perspective. Hawaii J Med Public Health. 2013 May; 72(5 Suppl 1):77-86.
-
Ichiho HM, Demei Y, Kuartei S, Aitaoto N. An assessment of non-communicable diseases, diabetes, and related risk factors in the Republic of Palau: a systems perspective. Hawaii J Med Public Health. 2013 May; 72(5 Suppl 1):98-105.
-
Luzze H, Johnson DF, Dickman K, Mayanja-Kizza H, Okwera A, Eisenach K, Cave MD, Whalen CC, Johnson JL, Boom WH, Joloba M. Relapse more common than reinfection in recurrent tuberculosis 1-2 years post treatment in urban Uganda. Int J Tuberc Lung Dis. 2013 Mar; 17(3):361-7.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|